Phase 4 Breast Cancer Trial, Not Yet Recruiting NCT06777537 Sponsor: Shandong University Condition: Breast Cancer
Back to Breast Cancer

Phase 4 Breast Cancer Trial, Not Yet Recruiting

NCT06777537
Not Yet Recruiting Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women between 18 and 75 years of age.
  • People whose breast cancer has been confirmed through laboratory tissue testing and protein marker testing.
  • People who have not received any anti-cancer medicines before surgery.
  • People whose liver and kidney function test results fall within acceptable ranges when checked within 3 days after surgery.
  • People whose blood test results (including red blood cells, platelets, and white blood cells) fall within acceptable ranges when checked within 3 days after surgery.
  • People whose life expectancy is at least 6 months.
  • People who are willing to sign a consent form agreeing to take part in the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have stage IV (advanced/spread) breast cancer.
  • People who are pregnant or currently breastfeeding.
  • People who have active bleeding for any reason.
  • People who have HIV infection or an AIDS-related illness.
  • People who have severe long-term or serious short-term health conditions.
  • People who have severe diabetes.
  • People who have a serious infectious disease.
  • People who are unable to swallow or take medicines by mouth.
  • People who misuse drugs, or who have a psychological or mental health condition that may affect their ability to follow the study requirements.
  • People whom the trial investigators consider unsuitable for the study for other reasons (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +8618560085168

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 4
Sponsor
Shandong University
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
1 December 2030

Primary endpoints

Disease free survival (DFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov